Renishaw plc (LON:RSW) announced a dividend on Thursday, January 25th, Upcoming.Co.Uk reports. Investors of record on Thursday, March 8th will be paid a dividend of GBX 14 ($0.19) per share on Monday, April 9th. This represents a dividend yield of 0.28%. The ex-dividend date is Thursday, March 8th. The official announcement can be viewed at this link.
Shares of RSW stock traded down GBX 26 ($0.36) during midday trading on Thursday, hitting GBX 4,506 ($62.25). 57,741 shares of the company were exchanged, compared to its average volume of 89,834. The company has a market capitalization of $3,480.00 and a price-to-earnings ratio of 2,384.13. Renishaw has a 52 week low of GBX 3,024 ($41.78) and a 52 week high of GBX 5,820 ($80.41).
Renishaw (LON:RSW) last posted its quarterly earnings data on Thursday, January 25th. The company reported GBX 72.70 ($1.00) earnings per share (EPS) for the quarter. The firm had revenue of £279.46 million during the quarter. Renishaw had a net margin of 20.07% and a return on equity of 23.90%.
In related news, insider Kath Durrant acquired 198 shares of the stock in a transaction that occurred on Thursday, January 25th. The stock was acquired at an average cost of GBX 5,035 ($69.56) per share, for a total transaction of £9,969.30 ($13,773.56).
TRADEMARK VIOLATION WARNING: This piece of content was reported by BBNS and is the property of of BBNS. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://baseballnewssource.com/2018/03/29/renishaw-plc-rsw-declares-dividend-of-gbx-14/1971138.html.
Renishaw Company Profile
Renishaw plc is a metrology company. The Company operates through two segments: metrology and healthcare. The Company’s metrology products are used in the fields of industrial automation and motion systems. The healthcare products include engineering solutions for stereotactic neurosurgery, diagnosis of infectious diseases, analytical tools that identify and characterize the chemistry and structure of materials, supply of implants to hospitals and specialist design centers for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture dental restorations.
Receive News & Ratings for Renishaw Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renishaw and related companies with MarketBeat.com's FREE daily email newsletter.